Rohm Labs Letrozole 2.5mg x 50 tablets

£33.00

Description
Reviews (0)

Rohm Labs Letrozole 2.5mg x 50 Tablets

Rohm Labs Letrozole 2.5mg x 50 tablets contain a potent non-steroidal aromatase inhibitor designed for strict estrogen management. This pharmaceutical–grade product is essential for breast cancer treatment protocols and advanced Post Cycle Therapy (PCT) for anabolic steroid users. The 2.5mg dosage represents the standard therapeutic unit, requiring careful splitting or infrequent administration due to its extreme potency. The 50–tablet package provides a substantial supply for extended monitoring or treatment cycles. Unlike steroidal inhibitors, this compound binds irreversibly to the aromatase enzyme, offering superior control over estradiol levels.

Key Features

Contains 2.5mg Letrozole per tablet for maximum potency
Irreversibly inhibits aromatase enzyme activity
50 tablets per package for long-term protocol support
Manufactured by Rohm Labs under strict pharmaceutical standards
Critical for treating hormone receptor-positive breast cancer
Essential for restoring natural testosterone production in PCT
Prevents estrogen-related side effects like gynecomastia
Sealed packaging ensures product stability and authenticity

Product Specifications

Active Ingredient: Letrozole
Concentration: 2.5mg per tablet
Package Size: 50 tablets
Manufacturer: Rohm Labs
Administration: Oral
Half-life: Approximately 2 days (48 hours)
Detection Time: Not typically screened in standard drug tests
Chemical Structure: Non-steroidal triazole derivative
Classification: Prescription medication / Controlled substance (varies by region)
Legality: Prescription required globally for medical use

Mechanism of Action

Letrozole functions as a competitive inhibitor of the aromatase enzyme (CYP19A1). This enzyme is responsible for converting androgens (testosterone and androstenedione) into estrogens (estradiol and estrone). Letrozole binds to the heme group of the cychrome P450 subunit of the enzyme, blocking the conversion process entirely. Unlike competitive inhibitors that allow some enzyme activity, Letrozole’s binding is effectively irreversible until the body synthesizes new enzymes.

By drastically reducing circulating estrogen levels, the compound removes the negative feedback loop on the hypothalamus and pituitary gland. In a normal physiological state, high estrogen signals the brain to stop producing Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH). When Letrozole suppresses estrogen, this inhibition is lifted. The pituitary gland responds by releasing massive amounts of LH and FSH. In men, this surge stimulates the testes to produce testosterone, making it a powerful tool for recovering from steroid-induced hypogonadism.

Metabolic Impact

The metabolic consequences of Letrozole use are profound and require careful management. The rapid and severe drop in estrogen can lead to “crashing,” a state where estrogen levels fall below physiological necessities. Estrogen is vital for bone density, joint lubrication, cardiovascular health, and cognitive function. Crashing estrogen results in severe joint pain, increased fracture risk, depression, anxiety, and libido loss.

Lipid profiles are negatively impacted, with significant reductions in HDL (good cholesterol) and potential increases in LDL (bad cholesterol). This shift increases the risk of cardiovascular events. Bone mineral density decreases with long-term use, necessitating monitoring for osteoporosis. Conversely, the resulting increase in testosterone can improve muscle mass retention and fat metabolism, though these benefits are often outweighed by the severe side effects if not managed correctly. The drug does not cause liver toxicity, as it is not 17-alpha-alkylated.

Where to Buy

Rohm Labs Letrozole must be sourced from licensed pharmaceutical distributors or registered pharmacies. Verify all suppliers through the official Rohm Labs website for authorized dealer lists. Avoid unregulated sources due to the high risk of counterfeit medications and incorrect dosing.

Counterfeit aromatase inhibitors pose severe health risks, including failed cancer treatment or permanent hormonal damage. Authentic packaging includes security verification codes and holographic seals. Contact Rohm Labs directly to validate batch numbers. Import laws are strict, and customs authorities frequently seize unauthorized shipments of prescription medications.

Legal acquisition requires a valid medical prescription for breast cancer treatment or specific hormonal disorders. Possession without a prescription is illegal in most jurisdictions.

Conclusion

Rohm Labs Letrozole 2.5mg x 50 tablets offer a powerful solution for estrogen suppression in medical and recovery contexts. Its irreversible mechanism provides unmatched control but demands extreme caution to avoid crashing estrogen levels. The 50-tablet package supports extended protocols under strict supervision.

Users must monitor blood work regularly to ensure estrogen remains within a safe, physiological range. The risks of bone loss, cardiovascular damage, and mental health issues are significant if misused. Authenticity verification is critical for safety. Responsible use under medical guidance is mandatory.